Table 1 Baseline demographic and clinical characteristics of the cohort studied (N = 330 patients).
Characteristic | Not failed (n = 151) | Failed (n = 179) | P-value |
|---|---|---|---|
Gender | |||
Male | 84(56) | 93(52) | 0.51 |
Female | 67(44) | 86(48) | |
Age [median years(IQR)] | 34(29–40) | 32(27–38) | 0.15 |
Socioeconomic status | |||
High status | 68(45) | 88(49) | 0.45 |
Low status | 83(55) | 91(51) | |
Baseline CD4 cell count (cells/μl) | |||
Median (IQR) | 331(193–467) | 323(208–431) | 0.74 |
< 200 | 40(27) | 38(21) | 0.28 |
200–350 | 41(27) | 62(35) | |
> 350 | 70(46) | 79(44) | |
WHO stage | |||
Stage 1&2 | 74(49) | 83(46) | 0.82 |
Stage 3 | 59(39) | 71(40) | |
Stage 4 | 18(12) | 25(14) |